Home LiteratureArticle Details
PMID: 7051196 Published · ppublish English Journal Article

Mechanism of neurotensin degradation by rat brain peptidases.

Regulatory peptides ·Vol. 3 ·No. 5-6 ·1982-05-00 ·Pages 397-404

McDermott JR, Smith AI, Edwardson JA, Griffiths EC

Abstract

Neurotensin is degraded by peptidases present in soluble and particulate (25000 x g) fractions of rat hypothalamus, thalamus, cortex and pituitary, the soluble fraction of the hypothalamus having the highest activity. High performance liquid chromatography and amino acid analysis were used to identify the degradation pathway. The main product in both fractions was [1-8]neurotensin and the corresponding C-terminal fragment [9-13]neurotensin was identified. [1-10]Neurotensin was also identified, proportionately more of this peptide being produced by the particulate rather than the soluble fraction. In the presence of dithiothreitol, [1-7]neurotensin and [1-10]neurotensin were major products particularly in the soluble fraction. These results suggest that the main sites of cleavage of neurotensin by rat brain peptidases are the Arg8-Arg9, Pro10-Tyr11 and Pro7-Arg8 bonds.

MeSH Terms
Amino Acid Sequence Amino Acids/analysis Animals Brain/enzymology,metabolism Chromatography, High Pressure Liquid Endopeptidases/metabolism Male Neurotensin/metabolism Rats Rats, Inbred Strains Subcellular Fractions/metabolism Time Factors
Chemicals
Amino Acids Neurotensin Endopeptidases
Authors & Affiliations
4 authors, click to expand affiliations / ORCID
McDermott J R
Smith A I
Edwardson J A
Griffiths E C
Article Info
Journal
Regulatory peptides
Abbr.
Regul Pept
ISSN
0167-0115
Published
1982-05-00
Pages
397-404
Language
English
Region
Netherlands
NLM ID
8100479
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com